2006The Chinese Journal of Clinical PharmacologyRequires access

Bioequivalence of domperidone orally disintegrating tablets in healthy volunteers

Liang Yan

Open publisher page 0 citations

Abstract

Objective To study the bioequivalence of domperidone orally disintegrating tablets in comparison with domperidone tablets in healthy volunteers. Methods The randomized and crossover study was conducted in 22 healthy volunteers.After a single dose of the drugs,the plasma concentration of domperidonce was determined by HPLC.Results Both the tested (domperidone orally disintegrating tablets) and reference (domperidone tablets) were fitted to one compartment model.The main pharmacokinetic parameters of the tested and reference domperidone were as follows:C_ max were (40.43±12.89) and (42.31±20.32)μg·mL~ -1 ;t_ max were (0.84±0.29) and (0.91±0.48)h;t_ 1/2(ke) were (11.23±5.06) and (10.13±4.02) h;AUC_ 0-tn were (187.61±81.20) and (189.07±97.69)μg·h·mL~ -1 ;AUC_ 0-∞ were (220.18±106.93) and (215.57±102.13) μg·h·mL~ -1 ;F_ 0-tn and F_ 0-∞ were (102.61±16.41) % and (101.96±16.06)% ,respectively.Conclusion The results of analysis show that the tested and reference are bioeqivalent.

About this research paper

What this paper is about

Objective To study the bioequivalence of domperidone orally disintegrating tablets in comparison with domperidone tablets in healthy volunteers. Methods The randomized and crossover study was conducted in 22 healthy volunteers.After a single dose of the drugs,the plasma concentration of domperidonce was determined by HPLC.Results Both the tested (domperidone orally disintegrating tablets) and reference (domperidone tablets) were fitted to one compartment model.The main pharmacokinetic parameters of the tested and reference domperidone were as follows:C_ max were (40.43±12.89) and (42.31±20.32)μg·mL~ -1 ;t_ max were (0.84±0.29) and (0.91±0.48)h;t_ 1/2(ke) were (11.23±5.06) and (10.13±4.02) h;AUC_ 0-tn were (187.61±81.20) and (189.07±97.69)μg·h·mL~ -1 ;AUC_ 0-∞ were (220.18±106.93) and (215.57±102.13) μg·h·mL~ -1 ;F_ 0-tn and F_ 0-∞ were (102.61±16.41) % and (101.96±16.06)% ,respectively.Conclusion The results of analysis show that the tested and reference are bioeqivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the bioequivalence of domperidone orally disintegrating tablets in comparison with domperidone tablets in healthy volunteers. Methods The randomized and crossover study was conducted in 22 healthy volunteers.After a single dose of the drugs,the plasma concentration of domperidonce was determined by HPLC.Results Both the tested (domperidone orally disintegrating tablets) and reference (domperidone tablets) were fitted to one compartment model.The main pharmacokinetic parameters of the tested and reference domperidone were as follows:C_ max were (40.43±12.89) and (42.31±20.32)μg·mL~ -1 ;t_ max were (0.84±0.29) and (0.91±0.48)h;t_ 1/2(ke) were (11.23±5.06) and (10.13±4.02) h;AUC_ 0-tn were (187.61±81.20) and (189.07±97.69)μg·h·mL~ -1 ;AUC_ 0-∞ were (220.18±106.93) and (215.57±102.13) μg·h·mL~ -1 ;F_ 0-tn and F_ 0-∞ were (102.61±16.41) % and (101.96±16.06)% ,respectively.Conclusion The results of analysis show that the tested and reference are bioeqivalent.

Key concepts: Domperidone, Bioequivalence, Crossover study, Pharmacokinetics, Medicine, Pharmacology, Bioavailability, Plasma concentration

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence of domperidone orally disintegrating tablets in healthy volunteers — Research Paper | ScholarLens